These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9892881)

  • 1. The monoethylglycinexylidide test for grading of liver cirrhosis.
    Fabris L; Jemmolo RM; Toffolo G; Paleari D; Viaggi S; Rigon M; Casagrande F; Lirussi F; Strazzabosco M; Cobelli C; Okolicsanyi L
    Aliment Pharmacol Ther; 1999 Jan; 13(1):67-75. PubMed ID: 9892881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of liver disease and food on plasma MEGX concentrations.
    Pritchard-Davies R; Gross AS; Shenfield GM
    Br J Clin Pharmacol; 1994 Mar; 37(3):298-301. PubMed ID: 8198941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
    Bhise SB; Dias RJ
    Indian J Gastroenterol; 2007; 26(4):167-9. PubMed ID: 17986743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB; von Schönfeld J; Erhard J; Breuer N; Lange R; Beste M; Goebell H; Eigler FW
    Transplantation; 1997 Feb; 63(4):538-41. PubMed ID: 9047147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
    Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
    Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of MEGX (monoethylglycinexylidide) and antipyrine tests in patients with liver cirrhosis.
    Wojcicki J; Kozlowski K; Drozdzik M; Wojcicki M
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):243-7. PubMed ID: 12587953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of liver function by the MEGX test in patients with schistosomiasis and cirrhosis.
    El Desoky ES; Ahmed AM; Nafeh MA; Ahmed HA; Schütz E; Armstrong VW; Oellerich M
    Clin Biochem; 1999 Apr; 32(3):207-12. PubMed ID: 10383082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.
    Orlando R; Piccoli P; De Martin S; Padrini R; Palatini P
    Br J Clin Pharmacol; 2003 Jan; 55(1):86-93. PubMed ID: 12534644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of monoethylglycinexylidide as preoperative liver function test in a rat model of liver cirrhosis and man.
    Kaneko H; Otsuka Y; Katagiri M; Maeda T; Tsuchiya M; Tamura A; Ishii T; Takagi S; Shiba T
    Clin Exp Med; 2001 Mar; 1(1):19-26. PubMed ID: 11467398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans.
    Reichel C; Skodra T; Nacke A; Spengler U; Sauerbruch T
    Br J Clin Pharmacol; 1998 Dec; 46(6):535-9. PubMed ID: 9862241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
    Huang YS; Lee SD; Deng JF; Wu JC; Lu RH; Lin YF; Wang YJ; Lo KJ
    J Hepatol; 1993 Aug; 19(1):140-7. PubMed ID: 8301034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Schulz M; Schmidt FW; Herrmann H
    Ther Drug Monit; 1990 May; 12(3):219-26. PubMed ID: 2349604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease.
    Testa R; Caglieris S; Risso D; Arzani L; Campo N; Alvarez S; Giannini E; Lantieri PB; Celle G
    Am J Gastroenterol; 1997 Dec; 92(12):2268-73. PubMed ID: 9399768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary gas chromatographic method for the measurement of small concentrations of monoethylglycinexylidide and lidocaine in plasma.
    Laroche N; Leneveu A; Roux A; Flouvat B
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):375-81. PubMed ID: 9824255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery.
    Ercolani G; Grazi GL; Callivà R; Pierangeli F; Cescon M; Cavallari A; Mazziotti A
    Surgery; 2000 Apr; 127(4):464-71. PubMed ID: 10776439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine metabolite formation as a measure of perioperative liver function.
    Shimanuki K; Sakurabayashi I; Miyata M; Kiyozaki H; Suzuki W; Kashii A; Seo N
    Surg Today; 1993; 23(4):315-9. PubMed ID: 8318785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs.
    Neumann S; Frenz M; Streit F; Oellerich M
    Can J Vet Res; 2011 Oct; 75(4):317-20. PubMed ID: 22468031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of age on plasma MEGX concentrations.
    Orlando R; Palatini P
    Br J Clin Pharmacol; 1997 Aug; 44(2):206-8. PubMed ID: 9278213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.